$HAE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HAEMONETICS CORP. Get notifications about new insider transactions in HAEMONETICS CORP for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 16 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 25.54 | 4,600 | 117,461 | 27,380 | |
Feb 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 0 | |
Feb 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 37.64 | 3,000 | 112,916 | 130,307 | 133.3 K to 130.3 K (-2.25 %) |
Feb 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 133,307 | 130.3 K to 133.3 K (+2.30 %) |
Feb 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 37.63 | 4,600 | 173,080 | 130,307 | 134.9 K to 130.3 K (-3.41 %) |
Feb 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 25.54 | 4,600 | 117,461 | 134,907 | 130.3 K to 134.9 K (+3.53 %) |
Jan 23 2014 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Option Exercise | A | 0.00 | 2,484 | 0 | 2,484 | |
Jan 23 2014 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Option Exercise | A | 42.26 | 24,873 | 1,051,133 | 24,873 | |
Jan 14 2014 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 27.28 | 4,000 | 109,100 | 3,206 | |
Jan 14 2014 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 41.80 | 4,000 | 167,186 | 16,905 | 20.9 K to 16.9 K (-19.13 %) |
Jan 14 2014 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 27.28 | 4,000 | 109,100 | 20,905 | 16.9 K to 20.9 K (+23.66 %) |
Jan 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 25.54 | 4,600 | 117,461 | 31,980 | |
Jan 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 3,000 | |
Jan 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.63 | 3,000 | 124,889 | 130,307 | 133.3 K to 130.3 K (-2.25 %) |
Jan 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 133,307 | 130.3 K to 133.3 K (+2.30 %) |
Jan 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.55 | 4,600 | 191,141 | 130,307 | 134.9 K to 130.3 K (-3.41 %) |
Jan 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 25.54 | 4,600 | 117,461 | 134,907 | 130.3 K to 134.9 K (+3.53 %) |
Dec 17 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 25.54 | 4,000 | 102,140 | 0 | |
Dec 17 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 43.50 | 4,000 | 173,982 | 16,905 | 20.9 K to 16.9 K (-19.13 %) |
Dec 17 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 25.54 | 4,000 | 102,140 | 20,905 | 16.9 K to 20.9 K (+23.66 %) |
Dec 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 25.54 | 4,600 | 117,461 | 36,580 | |
Dec 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 6,000 | |
Dec 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 42.33 | 3,000 | 126,980 | 130,307 | 133.3 K to 130.3 K (-2.25 %) |
Dec 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 133,307 | 130.3 K to 133.3 K (+2.30 %) |
Dec 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 42.29 | 4,600 | 194,548 | 130,307 | 134.9 K to 130.3 K (-3.41 %) |
Dec 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 25.54 | 4,600 | 117,461 | 134,907 | 130.3 K to 134.9 K (+3.53 %) |
Dec 10 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 25.54 | 3,138 | 80,129 | 4,000 | |
Dec 10 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 43.07 | 3,138 | 135,165 | 16,905 | 20 K to 16.9 K (-15.66 %) |
Dec 10 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 25.54 | 3,138 | 80,129 | 20,043 | 16.9 K to 20 K (+18.56 %) |
Nov 14 2013 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 39.82 | 2,062 | 82,109 | 9,939 | 12 K to 9.9 K (-17.18 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 39.06 | 9,836 | 384,145 | 29,508 | |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 30.67 | 18,660 | 572,302 | 18,666 | |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 27.49 | 2,800 | 76,958 | 17,036 | |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 27.49 | 30,104 | 827,408 | 19,836 | |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 39.66 | 2,800 | 111,051 | 10,987 | 13.8 K to 11 K (-20.31 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 27.49 | 2,800 | 76,958 | 13,787 | 11 K to 13.8 K (+25.48 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 39.70 | 30,104 | 1,195,156 | 10,987 | 41.1 K to 11 K (-73.26 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 27.49 | 30,104 | 827,408 | 41,091 | 11 K to 41.1 K (+274.00 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 39.70 | 18,660 | 740,819 | 10,987 | 29.6 K to 11 K (-62.94 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 30.67 | 18,660 | 572,302 | 29,647 | 11 K to 29.6 K (+169.84 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 39.70 | 9,836 | 390,498 | 10,987 | 20.8 K to 11 K (-47.24 %) |
Nov 13 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 39.06 | 9,836 | 384,145 | 20,823 | 11 K to 20.8 K (+89.52 %) |
Nov 14 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 39.62 | 1,188 | 47,069 | 16,905 | 18.1 K to 16.9 K (-6.57 %) |
Nov 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 25.54 | 4,600 | 117,461 | 41,180 | |
Nov 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 9,000 | |
Nov 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.96 | 3,000 | 119,881 | 130,307 | 133.3 K to 130.3 K (-2.25 %) |
Nov 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 133,307 | 130.3 K to 133.3 K (+2.30 %) |
Nov 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.96 | 4,600 | 183,806 | 130,307 | 134.9 K to 130.3 K (-3.41 %) |
Nov 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 25.54 | 4,600 | 117,461 | 134,907 | 130.3 K to 134.9 K (+3.53 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | D | 39.55 | 915 | 36,190 | 32,845 | 33.8 K to 32.8 K (-2.71 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | D | 39.55 | 655 | 25,906 | 33,760 | 34.4 K to 33.8 K (-1.90 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | D | 39.55 | 704 | 27,844 | 34,415 | 35.1 K to 34.4 K (-2.00 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | D | 39.55 | 335 | 13,250 | 35,119 | 35.5 K to 35.1 K (-0.94 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 39.55 | 2,975 | 117,666 | 130,307 | 133.3 K to 130.3 K (-2.23 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 39.55 | 3,318 | 131,233 | 133,282 | 136.6 K to 133.3 K (-2.43 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 39.55 | 1,211 | 47,897 | 136,600 | 137.8 K to 136.6 K (-0.88 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 41.09 | 3,191 | 131,118 | 137,811 | 141 K to 137.8 K (-2.26 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Option Exercise | A | 41.66 | 28,523 | 1,188,268 | 28,523 | |
Oct 29 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | D | 39.55 | 129 | 5,102 | 27,046 | 27.2 K to 27 K (-0.47 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | D | 39.55 | 298 | 11,786 | 27,175 | 27.5 K to 27.2 K (-1.08 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | D | 39.55 | 329 | 13,013 | 27,473 | 27.8 K to 27.5 K (-1.18 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 39.55 | 77 | 3,045 | 18,093 | 18.2 K to 18.1 K (-0.42 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 39.55 | 217 | 8,583 | 18,170 | 18.4 K to 18.2 K (-1.18 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 39.55 | 195 | 7,713 | 18,387 | 18.6 K to 18.4 K (-1.05 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 41.09 | 149 | 6,122 | 18,582 | 18.7 K to 18.6 K (-0.80 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | D | 39.55 | 350 | 13,843 | 10,987 | 11.3 K to 11 K (-3.09 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Option Exercise | A | 41.66 | 30,201 | 1,258,174 | 30,201 | |
Oct 29 2013 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | D | 39.55 | 432 | 17,086 | 28,950 | 29.4 K to 29 K (-1.47 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | D | 39.55 | 417 | 16,493 | 29,382 | 29.8 K to 29.4 K (-1.40 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | D | 39.55 | 238 | 9,413 | 29,799 | 30 K to 29.8 K (-0.79 %) |
Oct 25 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | A | 41.66 | 18,456 | 768,877 | 18,456 | |
Oct 25 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Grant | A | 0.00 | 1,980 | 0 | 18,731 | 16.8 K to 18.7 K (+11.82 %) |
Oct 29 2013 | HAE | HAEMONETICS CORP | Helsel Dave | EVP, Global Manufac ... | Option Exercise | A | 41.66 | 28,523 | 1,188,268 | 28,523 | |
Oct 29 2013 | HAE | HAEMONETICS CORP | Helsel Dave | EVP, Global Manufac ... | Sell | D | 41.09 | 246 | 10,108 | 9,670 | 9.9 K to 9.7 K (-2.48 %) |
Oct 25 2013 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Option Exercise | A | 41.66 | 28,523 | 1,188,268 | 28,523 | |
Oct 25 2013 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Grant | A | 0.00 | 3,060 | 0 | 11,740 | 8.7 K to 11.7 K (+35.25 %) |
Oct 25 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Grant | A | 0.00 | 3,060 | 0 | 27,802 | 24.7 K to 27.8 K (+12.37 %) |
Oct 25 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Grant | A | 0.00 | 3,060 | 0 | 27,802 | 24.7 K to 27.8 K (+12.37 %) |
Oct 25 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | A | 41.66 | 46,979 | 1,957,145 | 46,979 | |
Oct 25 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Grant | A | 0.00 | 5,040 | 0 | 35,454 | 30.4 K to 35.5 K (+16.57 %) |
Oct 25 2013 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Grant | A | 0.00 | 3,240 | 0 | 30,037 | 26.8 K to 30 K (+12.09 %) |
Oct 15 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 27.49 | 1,400 | 38,479 | 49,940 | |
Oct 15 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 40.41 | 1,400 | 56,568 | 11,337 | 12.7 K to 11.3 K (-10.99 %) |
Oct 15 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 27.49 | 1,400 | 38,479 | 12,737 | 11.3 K to 12.7 K (+12.35 %) |
Oct 25 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | A | 41.66 | 234,899 | 9,785,892 | 234,899 | |
Oct 25 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Grant | A | 0.00 | 25,204 | 0 | 141,002 | 115.8 K to 141 K (+21.77 %) |
Oct 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 12,000 | |
Oct 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.88 | 3,000 | 119,647 | 115,798 | 118.8 K to 115.8 K (-2.53 %) |
Oct 02 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 118,798 | 115.8 K to 118.8 K (+2.59 %) |
Sep 17 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 27.49 | 1,400 | 38,479 | 51,340 | |
Sep 17 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 40.36 | 1,400 | 56,507 | 11,337 | 12.7 K to 11.3 K (-10.99 %) |
Sep 17 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 27.49 | 1,400 | 38,479 | 12,737 | 11.3 K to 12.7 K (+12.35 %) |
Sep 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 15,000 | |
Sep 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 0 | |
Sep 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.87 | 10,000 | 398,676 | 115,798 | 125.8 K to 115.8 K (-7.95 %) |
Sep 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 125,798 | 115.8 K to 125.8 K (+8.64 %) |
Sep 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.87 | 3,000 | 119,609 | 115,798 | 118.8 K to 115.8 K (-2.53 %) |
Sep 04 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 118,798 | 115.8 K to 118.8 K (+2.59 %) |
Aug 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 18,000 | |
Aug 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 10,000 | |
Aug 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 42.22 | 10,000 | 422,244 | 115,798 | 125.8 K to 115.8 K (-7.95 %) |
Aug 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 125,798 | 115.8 K to 125.8 K (+8.64 %) |
Aug 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 42.30 | 3,000 | 126,900 | 115,798 | 118.8 K to 115.8 K (-2.53 %) |
Aug 05 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 118,798 | 115.8 K to 118.8 K (+2.59 %) |
Aug 01 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | D | 40.67 | 399 | 16,228 | 11,337 | 11.7 K to 11.3 K (-3.40 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Grant | A | 0.00 | 1,649 | 0 | 11,985 | 10.3 K to 12 K (+15.95 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 1,649 | 0 | 10,001 | 8.4 K to 10 K (+19.74 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | Zane Ellen M | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | Zane Ellen M | Director | Grant | A | 0.00 | 1,649 | 0 | 4,397 | 2.7 K to 4.4 K (+60.01 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.00 | 1,649 | 0 | 14,901 | 13.3 K to 14.9 K (+12.44 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 1,649 | 0 | 39,173 | 37.5 K to 39.2 K (+4.39 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Grant | A | 0.00 | 1,649 | 0 | 12,001 | 10.4 K to 12 K (+15.93 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Grant | A | 0.00 | 1,649 | 0 | 12,001 | 10.4 K to 12 K (+15.93 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | Black Paul | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | Black Paul | Director | Grant | A | 0.00 | 1,649 | 0 | 8,981 | 7.3 K to 9 K (+22.49 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.00 | 1,649 | 0 | 10,001 | 8.4 K to 10 K (+19.74 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Grant | A | 0.00 | 1,649 | 0 | 10,149 | 8.5 K to 10.1 K (+19.40 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | Nighan Warren JR | EVP, Global QA/RA | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | Helsel Dave | EVP, Global Manufac ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Jul 25 2013 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | D | 45.66 | 600 | 27,396 | 24,742 | 25.3 K to 24.7 K (-2.37 %) |
Jul 16 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 27.49 | 1,400 | 38,479 | 52,740 | |
Jul 16 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 44.10 | 1,400 | 61,740 | 11,736 | 13.1 K to 11.7 K (-10.66 %) |
Jul 16 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 27.49 | 1,400 | 38,479 | 13,136 | 11.7 K to 13.1 K (+11.93 %) |
Jul 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 13.05 | 3,000 | 39,158 | 21,000 | |
Jul 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 11.32 | 10,000 | 113,175 | 20,000 | |
Jul 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.88 | 10,000 | 418,820 | 115,798 | 125.8 K to 115.8 K (-7.95 %) |
Jul 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 11.32 | 10,000 | 113,175 | 125,798 | 115.8 K to 125.8 K (+8.64 %) |
Jul 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.84 | 3,000 | 125,522 | 115,798 | 118.8 K to 115.8 K (-2.53 %) |
Jul 03 2013 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 13.05 | 3,000 | 39,158 | 118,798 | 115.8 K to 118.8 K (+2.59 %) |
Jun 20 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | M | 26.32 | 68,628 | 1,805,946 | 29,412 | |
Jun 20 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | S | 42.50 | 68,628 | 2,916,690 | 30,414 | 99 K to 30.4 K (-69.29 %) |
Jun 20 2013 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Buy | M | 26.32 | 68,628 | 1,805,946 | 99,042 | 30.4 K to 99 K (+225.65 %) |
Jun 18 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | M | 27.49 | 1,400 | 38,479 | 54,140 | |
Jun 18 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | S | 42.17 | 1,400 | 59,034 | 11,736 | 13.1 K to 11.7 K (-10.66 %) |
Jun 18 2013 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Buy | M | 27.49 | 1,400 | 38,479 | 13,136 | 11.7 K to 13.1 K (+11.93 %) |